» Articles » PMID: 29691654

The Association Between 25-hydroxyvitamin D Concentration, Physical Performance and Frailty Status in Older Adults

Overview
Journal Eur J Nutr
Date 2018 Apr 26
PMID 29691654
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Sufficient 25-hydroxyvitamin D (25(OH)D) concentrations might prevent a decline in physical performance, and are considered important for the prevention of frailty. This study investigates the association of serum 25(OH)D concentration with physical performance and frailty status in Dutch older adults.

Methods: This cross-sectional study included 756 men and women, aged ≥ 65 years. Serum 25(OH)D concentration and frailty status (Fried criteria) were assessed in the total population. Screening for frailty status included functional tests of gait speed and hand grip strength. In a subgroup (n = 494), the Timed Up and Go test (TUG) and knee-extension strength were measured. Associations of serum 25(OH)D status with physical performance were examined by multiple linear regression. Prevalence ratios (PR) were used to quantify associations between serum 25(OH)D deficiency (< 50 nmol/L) and frailty.

Results: In total, 45% of the participants were vitamin D deficient. Participants with vitamin D status < 50 and 50-75 nmol/L had significantly lower scores on the TUG and gait speed test, compared to participants with vitamin D status > 75 nmol/L. No significant associations with serum 25(OH)D concentrations were observed for handgrip strength or knee-extension strength. Participants with serum 25(OH)D status < 50 nmol/L were about two times more likely to be frail compared to participants with serum 25(OH)D status ≥ 50 nmol/L. No significant associations were observed between the pre-frail state and serum 25(OH)D status.

Conclusion: In this study, serum 25(OH)D concentrations were significantly associated with frailty status and measures of physical performance, including gait speed and TUG, but not with strength-related outcomes.

Citing Articles

Frailty detection with routine blood tests using data from the english longitudinal study of ageing (ELSA).

He L, Yang J, Lin S, Shi K, Fang Y Eur Geriatr Med. 2024; 15(5):1347-1355.

PMID: 39190227 DOI: 10.1007/s41999-024-01038-2.


The association between dynamic changes in vitamin D and frailty alterations: A prospective analysis of UK Biobank participants.

Zhang P, Zhong J, Liu X, Sun W J Cachexia Sarcopenia Muscle. 2024; 15(5):1722-1732.

PMID: 38923848 PMC: 11446684. DOI: 10.1002/jcsm.13525.


Interaction of estradiol and vitamin D with low skeletal muscle mass among middle-aged and elderly women.

Zhang J, Cheng Y, Chen C, Wang Q, Yang C, Qiu J BMC Womens Health. 2023; 23(1):491.

PMID: 37715186 PMC: 10502989. DOI: 10.1186/s12905-023-02646-z.


Parkinson's Disease, SARS-CoV-2, and Frailty: Is There a Vicious Cycle Related to Hypovitaminosis D?.

Palermo S, Stanziano M, Nigri A, Civilotti C, Celeghin A Brain Sci. 2023; 13(4).

PMID: 37190492 PMC: 10137159. DOI: 10.3390/brainsci13040528.


Identification of Agents That Ameliorate Hyperphosphatemia-Suppressed Myogenin Expression Involved in the Nrf2/p62 Pathway in C2C12 Skeletal Muscle Cells.

Hsieh Li S, Liu S, Chang Y, Chen G, Huang S Int J Mol Sci. 2022; 23(23).

PMID: 36499650 PMC: 9736935. DOI: 10.3390/ijms232315324.


References
1.
Pfeifer M, Begerow B, Minne H, Abrams C, Nachtigall D, Hansen C . Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res. 2000; 15(6):1113-8. DOI: 10.1359/jbmr.2000.15.6.1113. View

2.
Fried L, Tangen C, Walston J, Newman A, Hirsch C, Gottdiener J . Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3):M146-56. DOI: 10.1093/gerona/56.3.m146. View

3.
Barros A, Hirakata V . Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003; 3:21. PMC: 521200. DOI: 10.1186/1471-2288-3-21. View

4.
Eyles D, Smith S, Kinobe R, Hewison M, McGrath J . Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2004; 29(1):21-30. DOI: 10.1016/j.jchemneu.2004.08.006. View

5.
Puts M, Visser M, Twisk J, Deeg D, Lips P . Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol (Oxf). 2005; 63(4):403-11. DOI: 10.1111/j.1365-2265.2005.02355.x. View